LYVE-1 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-LYVE-1 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityLYVE-1
Clone[4G1]
Host SpeciesMouse
Reactive Specieshuman
IsotypeIgG2b, k
FormatProtein G purified
Size0.05 mL, 0.1 mL
Concentration1mg/ml
ApplicationsELISA (EIA), Western Blot (WB), Flow Cytometry (FC/FACS), Immunocytochemistry (ICC), Immunofluorescence (IF)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionLymphatic vascular endothelial hyaluronan receptor-1 (LYVE-1), a selective marker of the lymphatic endothelium, is a surface endocytic receptor for hyaluronan (HA), which is an extracellular glycosaminoglycan involved in cell adhesion and migration. HA is widely expressed on leukocytes, dendritic cells, and tumor cell, and is identified by searching expressed sequence tag (EST) databases for sequences homologous (41%) with the metastasis related CD44 molecules.
ImmunogenImmunogen: Recombinant human LYVE-1 (25-235 aa) purified from E. coli
Other Names[XLkD1 (extracellular link domain containing 1); HAR; LYVE-1; CRSBP-1; lymphatic vessel endothelial hyaluronan receptor 1; extracellular link domain containing 1,], [LYVE1; LYVE1; HAR; XLKD1; LYVE-1; CRSBP-1; CRSBP1; HAR; XLKD1; LYVE-1; CRSBP-1]
Gene, Accession #[LYVE-1], Gene ID: 10894, NCBI: NP_006682, UniProt: Q9Y5Y7
Catalog #MBS200022
Price$240, $315
Order / More InfoLYVE-1 Antibody from MYBIOSOURCE INC.
Product Specific ReferencesKoukourakis MI. et al. (2006) J. Clin. Pathol. 58, 202-206; Chen L. et al. (2005) Invest. Ophthalmol Vis. Sci. 46, 4536-4540; Banerji S. et al. (1999) J. Cell Biol. 144, 789-801
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.